NCT05083169 2026-05-08MajesTEC-3Janssen Research & Development, LLCPhase 3 Active not recruiting587 enrolled 1 FDA
NCT04246047 2026-04-23DREAMM 7GlaxoSmithKlinePhase 3 Active not recruiting494 enrolled 10 charts 1 FDA
NCT03710603 2026-02-10PerseusEuropean Myeloma Network B.V.Phase 3 Active not recruiting709 enrolled 17 charts 1 FDA